We have observed
16 EP applications
Caroline Louise Johnston
has served for within the last five+ years.
(We consider all applications which have an EP A1 publication dated after
January 18, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Use of alpha-toxin for treating and preventing staphylococcus infections
BIOCONJUGATE VACCINES MADE IN PROKARYOTIC CELLS
BIOCONJUGATES COMPRISING MODIFIED ANTIGENS AND USES THEREOF
METHODS OF HOST CELL MODIFICATION
PRODUCTION OF RECOMBINANT VACCINE IN E. COLI BY ENZYMATIC CONJUGATION
METHODS AND COMPOSITIONS RELATING TO CRM197
METHOD OF TREATMENT
IMMUNOGENIC COMPOSITION FOR USE IN THERAPY
MODIFIED HOST CELLS AND USES THEREOF
CLOSTRIDIUM DIFFICILE IMMUNOGENIC COMPOSITION
COMPOSITIONS AND METHODS FOR PROTEIN GLYCOSYLATION